Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 26:2020:9081813.
doi: 10.1155/2020/9081813. eCollection 2020.

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease

Juana P Sánchez-Villamil  1   2 , Paula K Bautista-Niño  1 , Norma C Serrano  1 , Melvin Y Rincon  1 , Nisha J Garg  3
Affiliations
Review

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease

Juana P Sánchez-Villamil et al. Oxid Med Cell Longev. .

Abstract

Chagas disease (CD) is one of the most important neglected tropical diseases in the American continent. Host-derived nitroxidative stress in response to Trypanosoma cruzi infection can induce tissue damage contributing to the progression of Chagas disease. Antioxidant supplementation has been suggested as adjuvant therapy to current treatment. In this article, we synthesize and discuss the current evidence regarding the use of antioxidants as adjunctive compounds to fight harmful reactive oxygen species and lower the tissue oxidative damage during progression of chronic Chagas disease. Several antioxidants evaluated in recent studies have shown potential benefits for the control of oxidative stress in the host's tissues. Melatonin, resveratrol, the combination of vitamin C/vitamin E (vitC/vitE) or curcumin/benznidazole, and mitochondria-targeted antioxidants seem to be beneficial in reducing plasma and cardiac levels of lipid peroxidation products. Nevertheless, further research is needed to validate beneficial effects of antioxidant therapies in Chagas disease.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no financial or other competing interests.

References

    1. Fitzpatrick C., Nwankwo U., Lenk E., de Vlas S. J., Bundy D. A. P. An investment case for ending neglected tropical diseases. In: Holmes K. K., Bertozzi S., Bloom B. R., Jha P., editors. Washington (DC): Major Infectious Diseases; 2017. - PubMed
    1. Curtis-Robles R., Meyers A. C., Auckland L. D., Zecca I. B., Skiles R., Hamer S. A. Parasitic interactions among Trypanosoma cruzi, triatomine vectors, domestic animals, and wildlife in Big Bend National Park along the Texas-Mexico border. Acta Tropica. 2018;188:225–233. doi: 10.1016/j.actatropica.2018.09.002. - DOI - PubMed
    1. Curtis-Robles R., Snowden K. F., Dominguez B., et al. Epidemiology and molecular typing of Trypanosoma cruzi in naturally-infected hound dogs and associated triatomine vectors in Texas, USA. PLoS Neglected Tropical Diseases. 2017;11(1, article e0005298) doi: 10.1371/journal.pntd.0005298. - DOI - PMC - PubMed
    1. Garcia M. N., Burroughs H., Gorchakov R., et al. Molecular identification and genotyping of Trypanosoma cruzi DNA in autochthonous Chagas disease patients from Texas, USA. Infection, Genetics and Evolution. 2017;49:151–156. doi: 10.1016/j.meegid.2017.01.016. - DOI - PubMed
    1. Coura J. R., Vinas P. A. Chagas disease: a new worldwide challenge. Nature. 2010;465(7301):S6–S7. doi: 10.1038/nature09221. - DOI - PubMed